Published in Healthcare Finance, Tax and Law Weekly, January 31st, 2007
In addition, NQCI has terminated all of the transactions and other documents and agreements between NQCI and Xcorporeal that are referenced in or contemplated by the merger agreement or the license agreement. NQCI stated in its termination notice to Xcorporeal that NQCI had exercised its termination rights with respect to such agreements, documents and transactions on the basis of Xcorporeal's continuing, uncured and uncurable breaches of the merger agreement and its fraudulent and other wrongful conduct related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly